UNC Reaches Milestone in Development of Kinase Chemogenomic Set
August 2, 2017
The Structural Genomics Consortium at the University of North Carolina at Chapel Hill in partnership with the DiscoverX Corporation has reached the halfway point in developing a set of selective and potent inhibitors that will be made freely available to … Read more